Arthroscopic rotator cuff repair. Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder
Conditions
Interventions
Intervention 1: Intervention group: Daily use of 20 µg of rhPTH drug subcutaneously for 3 months. Intervention 2: Control group: placebo consumption for three months including mannitol, sodium aceta
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
50 Years to 80 Years
Inclusion criteria
Inclusion criteria: Diagnosis of rotator cuff rupture clinically and with MRI findings. Patient Informed Consent is obtained
Exclusion criteria
Exclusion criteria: Refusal to participate in the study Previous shoulder surgery History of shoulder septic arthritis Patients with combined shoulder surgeries than rotator cuff repair Non-operable rotator cuff tear Contraindication in using Recombinant Human Parathyroid Hormone (rhPTH) Patients under radiation therpay Known case of any psychological disorders Pregnancy Hypo/Hyper Calcemia/Calciuria
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Shoulder Range of Motion (Active/Passive Flexion and External Rotation). Timepoint: 6 months and 1 year. Method of measurement: Physical examination based on degrees.;Post-operative pain score. Timepoint: 6 months and 1 year. Method of measurement: Visual Analogue Scale.;Rotator Cuff Healing. Timepoint: 1 year. Method of measurement: By MRI evaluation via Sugaya score.;Shoulder Function. Timepoint: pre-op and 1 year post-op. Method of measurement: ASES Score. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAmir Human Hoveidaei
Tehran University of Medical Sciences
Outcome results
None listed